A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
A phase 2 trial of Adagrasib, Pembrolizumab, Cetuximab, Pemetrexed, Docetaxel and Oxaliplatin in advanced solid tumours, run by Mirati Therapeutics Inc., now recruiting.
Overview
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies is a phase 2 interventional study registered as NCT07415031 by Mirati Therapeutics Inc., with 170 participants planned, started 2026-05-06 and due to reach its primary completion in 2028-02-16. Interventions recorded: Adagrasib, Pembrolizumab, Cetuximab, Pemetrexed, Docetaxel and Irinotecan.
Similar pages
not linked directly; found by shared links- TrialCombination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
Shares Adagrasib, Pemetrexed, Bristol Myers Squibb, Pembrolizumab and the tag pipeline.
- TrialA Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Shares Adagrasib, Pemetrexed, Bristol Myers Squibb, Pembrolizumab and the tag pipeline.
- TrialA Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Shares Cetuximab, Pemetrexed, Pembrolizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
Shares Oxaliplatin, Docetaxel, Pemetrexed, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialStudy of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
Shares Oxaliplatin, Cetuximab, Pembrolizumab and the tag pipeline.
- TrialA Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Shares Oxaliplatin, Pembrolizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
Shares Docetaxel, Pemetrexed, Bristol Myers Squibb and the tag pipeline.
- TrialA Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Shares Cetuximab, Pemetrexed, Metastatic cancer (cancer that has spread) and the tag pipeline.